생체 외과용 의료기기 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of biosurgery devices Market

The global biosurgery devices market size was valued at USD 11.51 billion in 2025 and is projected to grow from USD 12.18 billion in 2026 to USD 19.99 billion by 2034, exhibiting a CAGR of 6.4% from 2026 to 2034. North America dominated the global market with a 45.7% share in 2025, supported by increasing surgical procedures, an aging population, advanced healthcare infrastructure, and adoption of innovative biosurgery technologies.

Biosurgery devices include hemostatic agents, surgical sealants and adhesives, bone graft substitutes, adhesion prevention products, and other products used during and after surgical procedures. These devices help control bleeding, close wounds, repair tissues, and improve surgical outcomes. Growing surgical volumes, faster recovery requirements, technological advancements, and increasing product launches are supporting market expansion.

Market Size and Value by Year

• 2025: USD 11.51 billion
• 2026: USD 12.18 billion
• 2034: USD 19.99 billion
• CAGR, 2026-2034: 6.4%

Market Definition and Scope

The biosurgery devices market covers products used for hemostasis, tissue sealing, wound closure, tissue repair, adhesion prevention, and bone regeneration. The market is segmented by product type, material, application, and end-user, with applications across orthopedic, cardiovascular, neurological, gynecological, and other surgical procedures.

Market Dynamics

Market Drivers: The increasing number of surgical procedures globally is a major driver. Growing procedures for cancer, cardiovascular diseases, trauma, obesity, and orthopedic conditions are increasing demand for hemostats, sealants, tissue repair products, and other biosurgery solutions. The emphasis on improved surgical outcomes and faster recovery is further supporting adoption.

Market Restraints: Strict regulatory requirements can delay product approvals and market entry. Biosurgery products often require extensive safety testing and clinical studies because they interact directly with blood, tissues, or organs. These requirements can increase development costs, particularly for smaller manufacturers.

Market Opportunities: The growing preference for minimally invasive and day-care surgeries is creating opportunities for biosurgery products designed for laparoscopic, robotic, and endoscopic procedures. Products that provide rapid sealing and hemostasis can support shorter procedures and faster patient discharge.

Market Trends: Increasing use of absorbable and tissue-friendly materials is an important trend. New hemostats, sealants, patches, and graft materials are being developed to reduce long-term residue and improve compatibility with human tissue.

Market Challenges: Storage and handling requirements can restrict adoption. Some sealants, patches, and hemostatic products require refrigeration, preparation, mixing, activation, or use within specific time windows, which can complicate workflows in busy surgical settings.

Segmentation Analysis

By Product Type: Hemostatic agents held the largest market share in 2025 because they are widely used across general, orthopedic, cardiac, spine, cancer, and trauma surgeries. Surgical sealants and adhesives are projected to grow at a 7.1% CAGR.

By Material: Biological materials dominated the market in 2025 due to their biocompatibility, absorbability, and lower risk of adverse reactions. This segment is expected to hold a 65.3% share in 2026. Synthetic materials are projected to grow at a 6.8% CAGR.

By Application: Orthopedic surgery dominated the market in 2025 and is expected to hold a 35.8% share in 2026, supported by the high prevalence of musculoskeletal conditions and continued technological development. Cardiovascular surgery is projected to grow at a 7.1% CAGR.

By End-User: Hospitals and clinics accounted for the largest share in 2025 and are expected to hold a 64.2% share in 2026. Academic and research institutes are projected to grow at a 6.5% CAGR.

Regional Insights

North America: North America remained the leading region, reaching USD 5.26 billion in 2025. The U.S. market is estimated to reach USD 5.24 billion in 2026, supported by increasing procedure volumes and technological advancements.

Europe: Europe is projected to grow at a 5.4% CAGR and reach USD 3.40 billion in 2026. Germany, the U.K., and France are major markets, with respective 2026 values of USD 0.76 billion, USD 0.55 billion, and USD 0.45 billion.

Asia Pacific: Asia Pacific is expected to reach USD 2.36 billion in 2026, while China and India are estimated at USD 0.78 billion and USD 0.52 billion, respectively.

Latin America and Middle East & Africa: Latin America is projected to reach USD 0.50 billion in 2026, while the GCC is expected to reach USD 0.13 billion.

Competitive Landscape

Major companies include Johnson & Johnson Services Inc., Baxter International, Medtronic, BD, Integra LifeSciences, Zimmer Biomet, Stryker, CSL Behring, B. Braun Melsungen AG, and 3M. Competition is driven by product innovation, regulatory approvals, strategic partnerships, acquisitions, collaborations, and expansion into emerging markets.

Recent developments include Cerapedics receiving FDA approval for PearlMatrix P-15 Peptide enhanced bone graft in June 2025, Axogen launching Avive+ tissue matrix in June 2024, and Olympus launching EndoClot hemostatic agents in Europe in April 2023.

Report Coverage

The report covers biosurgery devices market size and forecast, product types, materials, applications, end-users, regional markets, market drivers, restraints, opportunities, trends, challenges, competitive landscape, product launches, approvals, partnerships, acquisitions, and major industry developments.

Conclusion

The global biosurgery devices market is expanding alongside the rising number of surgical procedures and increasing demand for effective bleeding control, wound closure, tissue repair, and faster recovery. The market is valued at USD 11.51 billion in 2025, projected to reach USD 12.18 billion in 2026, and expected to reach USD 19.99 billion by 2034. North America remains the largest regional market, while minimally invasive procedures, absorbable materials, biological products, and continued product innovation are creating further opportunities. Increasing adoption of advanced surgical technologies is expected to support market development through 2034.

Segmentation By Product Type

• Hemostatic Agents
• Surgical Sealants & Adhesives
• Bone Graft Substitutes
• Adhesion Prevention Products
• Others

By Material

• Biological
• Synthetic

By Application

• Orthopedic Surgery
• Cardiovascular Surgery
• Neurosurgery
• Gynecological Surgery
• Others

By End-user

• Hospitals & Clinics
• Academic & Research Institutes
• Others

By Region

• North America (By Product Type, Material, Application, End-user, and Country)
  • U.S. (By Product Type)
  • Canada (By Product Type)
• Europe (By Product Type, Material, Application, End-user, and Country/Sub-region)
  • Germany (By Product Type)
  • U.K. (By Product Type)
  • France (By Product Type)
  • Spain (By Product Type)
  • Italy (By Product Type)
  • Scandinavia (By Product Type)
  • Rest of Europe (By Product Type)
• Asia Pacific (By Product Type, Material, Application, End-user, and Country/Sub-region)
  • China (By Product Type)
  • Japan (By Product Type)
  • India (By Product Type)
  • Australia (By Product Type)
  • Southeast Asia (By Product Type)
  • Rest of Asia Pacific (By Product Type)
• Latin America (By Size, Procedure, End-user, and Country/Sub-region)
  • Brazil (By Product Type)
  • Mexico (By Product Type)
  • Rest of Latin America (By Product Type)
• Middle East & Africa (By Product Type, Material, Application, End-user, and Country/Sub-region)
  • GCC (By Product Type)
  • South Africa (By Product Type)
  • Rest of the Middle East & Africa (By Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
• 4.2. Technological Advancements in Biosurgery Devices
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Biosurgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Hemostatic Agents
  • 5.1.2. Surgical Sealants & Adhesives
  • 5.1.3. Bone Graft Substitutes
  • 5.1.4. Adhesion Prevention Products
  • 5.1.5. Others
• 5.2. Market Analysis, Insights and Forecast - By Material
  • 5.2.1. Biological
  • 5.2.2. Synthetic
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Orthopedic Surgery
  • 5.3.2. Cardiovascular Surgery
  • 5.3.3. Neurosurgery
  • 5.3.4. Gynecological Surgery
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & Clinics
  • 5.4.2. Academic & Research Institutes
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East and Africa

6. North America Biosurgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Hemostatic Agents
  • 6.1.2. Surgical Sealants & Adhesives
  • 6.1.3. Bone Graft Substitutes
  • 6.1.4. Adhesion Prevention Products
  • 6.1.5. Others
• 6.2. Market Analysis, Insights and Forecast - By Material
  • 6.2.1. Biological
  • 6.2.2. Synthetic
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Orthopedic Surgery
  • 6.3.2. Cardiovascular Surgery
  • 6.3.3. Neurosurgery
  • 6.3.4. Gynecological Surgery
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & Clinics
  • 6.4.2. Academic & Research Institutes
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Product Type
  • 6.5.2. Canada
    • 6.5.2.1. By Product Type

7. Europe Biosurgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Hemostatic Agents
  • 7.1.2. Surgical Sealants & Adhesives
  • 7.1.3. Bone Graft Substitutes
  • 7.1.4. Adhesion Prevention Products
  • 7.1.5. Others
• 7.2. Market Analysis, Insights and Forecast - By Material
  • 7.2.1. Biological
  • 7.2.2. Synthetic
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Orthopedic Surgery
  • 7.3.2. Cardiovascular Surgery
  • 7.3.3. Neurosurgery
  • 7.3.4. Gynecological Surgery
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Academic & Research Institutes
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Product Type
  • 7.5.2. Germany
    • 7.5.2.1. By Product Type
  • 7.5.3. France
    • 7.5.3.1. By Product Type
  • 7.5.4. Spain
    • 7.5.4.1. By Product Type
  • 7.5.5. Italy
    • 7.5.5.1. By Product Type
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Product Type
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Product Type

8. Asia Pacific Biosurgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Hemostatic Agents
  • 8.1.2. Surgical Sealants & Adhesives
  • 8.1.3. Bone Graft Substitutes
  • 8.1.4. Adhesion Prevention Products
  • 8.1.5. Others
• 8.2. Market Analysis, Insights and Forecast - By Material
  • 8.2.1. Biological
  • 8.2.2. Synthetic
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Orthopedic Surgery
  • 8.3.2. Cardiovascular Surgery
  • 8.3.3. Neurosurgery
  • 8.3.4. Gynecological Surgery
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & Clinics
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Product Type
  • 8.5.2. Australia
    • 8.5.2.1. By Product Type
  • 8.5.3. China
    • 8.5.3.1. By Product Type
  • 8.5.4. India
    • 8.5.4.1. By Product Type
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Product Type
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Product Type

9. Latin America Biosurgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Hemostatic Agents
  • 9.1.2. Surgical Sealants & Adhesives
  • 9.1.3. Bone Graft Substitutes
  • 9.1.4. Adhesion Prevention Products
  • 9.1.5. Others
• 9.2. Market Analysis, Insights and Forecast - By Material
  • 9.2.1. Biological
  • 9.2.2. Synthetic
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Orthopedic Surgery
  • 9.3.2. Cardiovascular Surgery
  • 9.3.3. Neurosurgery
  • 9.3.4. Gynecological Surgery
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & Clinics
  • 9.4.2. Academic & Research Institutes
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Product Type
  • 9.5.2. Mexico
    • 9.5.2.1. By Product Type
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Product Type

10. Middle East and Africa Biosurgery Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Hemostatic Agents
  • 10.1.2. Surgical Sealants & Adhesives
  • 10.1.3. Bone Graft Substitutes
  • 10.1.4. Adhesion Prevention Products
  • 10.1.5. Others
• 10.2. Market Analysis, Insights and Forecast - By Material
  • 10.2.1. Biological
  • 10.2.2. Synthetic
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Orthopedic Surgery
  • 10.3.2. Cardiovascular Surgery
  • 10.3.3. Neurosurgery
  • 10.3.4. Gynecological Surgery
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals & Clinics
  • 10.4.2. Academic & Research Institutes
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Product Type
  • 10.5.2. GCC
    • 10.5.2.1. By Product Type
  • 10.5.3. Rest of Middle East and Africa
    • 10.5.3.1. By Product Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Johnson & Johnson Services Inc.
  • 11.2.2. Baxter
  • 11.2.3. Medtronic
  • 11.2.4. BD
  • 11.2.5. Integra LifeSciences
  • 11.2.6. Zimmer Biomet
  • 11.2.7. Stryker Corporation
  • 11.2.8. CSL Behring
  • 11.2.9. B. Braun Melsungen AG
  • 11.2.10. 3M